| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.071 | 0.4 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |